Small Company Offering and Sale of Securities Without Registration (d)
July 14 2020 - 3:04PM
Edgar (US Regulatory)
o
NoneEntity Type | 0001614744 | Mainrom Line Logistics Ltd. Kitov Pharmaceuticals Holdings Ltd. |
o
Corporation
o
Limited Partnership
o
Limited Liability Company
o
General Partnership
o
Business Trust
x
Other Limited company |
Name of Issuer |
Kitov Pharma Ltd. |
Jurisdiction of Incorporation/Organization |
ISRAEL |
|
Year of Incorporation/Organization |
|
x
| Over Five Years Ago |
|
o
| Within Last Five Years (Specify Year) | |
|
o
| Yet to Be Formed | |
2. Principal Place of Business and Contact Information |
Name of Issuer | |
Kitov Pharma Ltd. | |
Street Address 1 | Street Address 2 |
ONE AZRIELI CENTER, ROUND TOWER | 132 MENACHEM BEGIN ROAD |
City | State/Province/Country | ZIP/Postal Code | Phone No. of Issuer |
TEL AVIV | ISRAEL | 6701101 | 97239333121 |
Last Name | First Name | Middle Name |
Israel | Isaac | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
x
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Chief Executive Officer and Director of the Issuer |
Last Name | First Name | Middle Name |
Rowinsky | Eric | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Independent Director and Chairman of the Board of Directors of the Issuer |
Last Name | First Name | Middle Name |
Rock | Simcha | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Director of the Issuer |
Last Name | First Name | Middle Name |
Steinberg | Steven | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Independent Director of the Issuer |
Last Name | First Name | Middle Name |
Agmon | Ido | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Independent Director of the Issuer |
Last Name | First Name | Middle Name |
Tzror | Ran | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Independent Director of the Issuer |
Last Name | First Name | Middle Name |
Stern-Raff | Revital | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
o
| Executive Officer |
x
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Independent Director of the Issuer |
Last Name | First Name | Middle Name |
Reuveni | Hadas | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| VP R&D of the Issuer |
Last Name | First Name | Middle Name |
Efron | Gil | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Deputy CEO and Chief Financial Officer of the Issuer |
Last Name | First Name | Middle Name |
Liang | Bertrand | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Chief Medical Officer of the Issuer |
Last Name | First Name | Middle Name |
Schickler | Michael | |
Street Address 1 | Street Address 2 |
One Azrieli Center | Round Building |
City | State/Province/Country | ZIP/Postal Code |
Tel Aviv | ISRAEL | 6701101 |
Relationship: |
x
| Executive Officer |
o
| Director |
o
| Promoter |
Clarification of Response (if Necessary) |
| Head of Clinical Operations of the Issuer |
o
| Agriculture | | Health Care |
o
| Retailing |
| Banking & Financial Services | |
o
| Biotechnology |
o
| Restaurants |
|
o
| Commercial Banking | |
o
| Health Insurance | | Technology |
|
o
| Insurance | |
o
| Hospitals & Physicians | |
o
| Computers |
|
o
| Investing | |
x
| Pharmaceuticals | |
o
| Telecommunications |
|
o
| Investment Banking | |
o
| Other Health Care | |
o
| Other Technology |
|
o
| Pooled Investment Fund
| | | | | Travel |
|
o
| Other Banking & Financial Services |
o
| Manufacturing | |
o
| Airlines & Airports |
| Real Estate | |
o
| Lodging & Conventions |
|
o
| Commercial | |
o
| Tourism & Travel Services |
|
o
| Construction | |
o
| Other Travel |
|
o
| REITS & Finance |
o
| Other |
|
o
| Residential | |
|
o
| Other Real Estate | |
o
| Business Services | |
| Energy | |
|
o
| Coal Mining | |
|
o
| Electric Utilities | |
|
o
| Energy Conservation | |
|
o
| Environmental Services | |
|
o
| Oil & Gas | |
|
o
| Other Energy | |
Revenue Range | Aggregate Net Asset Value Range |
o
| No Revenues |
o
| No Aggregate Net Asset Value |
o
| $1 - $1,000,000 |
o
| $1 - $5,000,000 |
o
| $1,000,001 - $5,000,000 |
o
| $5,000,001 - $25,000,000 |
o
| $5,000,001 - $25,000,000 |
o
| $25,000,001 - $50,000,000 |
o
| $25,000,001 - $100,000,000 |
o
| $50,000,001 - $100,000,000 |
o
| Over $100,000,000 |
o
| Over $100,000,000 |
x
| Decline to Disclose |
o
| Decline to Disclose |
o
| Not Applicable |
o
| Not Applicable |
6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) |
o
| Rule 504(b)(1) (not (i), (ii) or (iii)) |
o
| Rule 505 |
o
| Rule 504 (b)(1)(i) |
x
| Rule 506(b) |
o
| Rule 504 (b)(1)(ii) |
o
| Rule 506(c) |
o
| Rule 504 (b)(1)(iii) |
o
| Securities Act Section 4(a)(5) |
|
o
| Investment Company Act Section 3(c) |
x
| New Notice | Date of First Sale | 2020-05-24 |
o
| First Sale Yet to Occur |
Does the Issuer intend this offering to last more than one year? |
o
| Yes |
x
| No |
9. Type(s) of Securities Offered (select all that apply) |
o
| Pooled Investment Fund Interests |
x
| Equity |
o
| Tenant-in-Common Securities |
o
| Debt |
o
| Mineral Property Securities |
o
| Option, Warrant or Other Right to Acquire Another Security |
o
| Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security |
o
| Other (describe) |
| |
10. Business Combination Transaction |
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? |
o
| Yes |
x
| No |
|
Clarification of Response (if Necessary) | |
|
Minimum investment accepted from any outside investor | $ 0 USD |
Recipient | Recipient CRD Number |
x
| None |
NONE | |
(Associated) Broker or Dealer |
x
| None | (Associated) Broker or Dealer CRD Number |
x
| None |
| |
Street Address 1 | Street Address 2 |
NONE | NONE |
City | State/Province/Country | ZIP/Postal Code |
NONE | Unknown | 00000 |
State(s) of Solicitation |
o
| All States |
o
| Foreign/Non-US |
NEW YORK |
13. Offering and Sales Amounts |
Total Offering Amount | $ USD |
x
Indefinite |
Total Amount Sold | $ 0 USD | |
Total Remaining to be Sold | $ USD |
x
Indefinite |
|
Clarification of Response (if Necessary) |
Private placements of 812,500 of Filer's ADSs previously issued in June 2020, and 486,111 of Filer's ADSs to be issued in July 2020 to a former placement agent as part of a tail fee in connection with Filer's 2020 offerings. |
o
| Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering
| |
| Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: | 1 |
15. Sales Commissions & Finders’ Fees Expenses |
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
|
Sales Commissions | $ 0 USD |
o
| Estimate |
Finders' Fees | $ 0 USD |
o
| Estimate |
|
Clarification of Response (if Necessary) |
|
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
|
| $ 0 USD |
o
Kitov Pharma (NASDAQ:KTOVW) Historical Stock Chart From Oct 2024 to Nov 2024
Kitov Pharma (NASDAQ:KTOVW) Historical Stock Chart From Nov 2023 to Nov 2024
Real-Time news about Kitov Pharma Ltd (NASDAQ): 0 recent articles
More Kitov Pharma Ltd. News Articles
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|